Shares of TriSalus Life Sciences Inc. (NASDAQ: TLSI) trade dynamically on public exchanges, with equity valuations responding directly to commercial adoption rates of its proprietary vascular delivery systems, quarterly revenue growth disclosures, and overall market sentiment across the medical device sector.